In vitro study of normoxic epidermal growth factor receptor–induced hypoxia‐inducible factor‐1‐alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti–epidermal growth factor receptor therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|8|1150-1162

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.8, 2015-08, pp. : 1150-1162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 Upregulates p27KIP1 and p15INK4B and Induces G1 Arrest in Oral Squamous Carcinoma Cell Lines

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 92-98

Karger

Access to resources Recommend Favorite

Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 10, 2015-11 ,pp. : 818-822

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of transitional cell carcinoma by targeting the epidermal growth factor receptor

By Brook Nicholas R   Colquhoun Alex J   Mellon J Kilian  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 407-416

Future Medicine

Access to resources Recommend Favorite

Effects of the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab on Cholangiocarcinoma of the Liver

By  

Oncology Research and Treatment, Vol. 30, Iss. 3, 2007-02 ,pp. : 129-131

Karger

Access to resources Recommend Favorite

Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 10, 2015-10 ,pp. : 1410-1416

John Wiley & Sons Inc

Access to resources Recommend Favorite